Your second dose of Mounjaro: what to expect and how to read your body's response

Step 1, Picking up where week one left off

By the time your second dose is due, the tirzepatide from your first injection has largely cleared your system, so you are not stacking doses; you are restarting a weekly rhythm. Many people find the second week feels familiar: a dip in appetite, possibly some queasiness in the first couple of days, and a gradual settling by the weekend. Others notice very little change at all, which is equally common at this stage.

The 2.5 mg dose is deliberately calibrated to ease your body into the medicine rather than produce rapid weight loss straight away. Its job is tolerance, not transformation. If week one was rougher than you expected, week two often runs a little smoother once your digestive system has had its first introduction. If week one was uneventful, do not assume week two will be harder, there is no reliable pattern there.

One practical habit worth building now: spend sixty seconds each morning rating your nausea, energy and appetite out of ten and noting it in your phone. That log becomes genuinely useful when your prescriber reviews your progress before any dose increase. Our guide to the first Mounjaro dose covers the baseline experience most people have in week one, which is helpful to compare against.

Step 2, The injection itself at week two

The technique is identical to week one, but the site should not be. Rotating your injection point (between the abdomen, the front of the thigh and the outer upper arm) reduces the chance of localised skin irritation building up at a single spot. If you injected into your left thigh last week, try the abdomen or right thigh this time. Full step-by-step injection guidance is on our how to inject your second Mounjaro dose page.

Storage matters here too. Your pen should have remained refrigerated at 2–8°C since it arrived. Before injecting, let it reach room temperature for a few minutes, a cold pen can sting more. For the precise room-temperature window you have available, check the Patient Information Leaflet that came with your pen; that is the document your prescriber and the manufacturer defer to on storage questions, and it is worth reading end to end at least once.

If you are unsure about any part of the process, the nume FAQs cover the questions our prescribers field most often, and the contact team is available seven days a week.

Step 3, What side effects are normal now, and what warrants attention

At week two, gastrointestinal symptoms remain the most commonly reported: nausea, loose stools or constipation, burping, and a feeling of fullness that arrives much faster than usual at mealtimes. These are on-target effects of how the medicine slows gastric emptying. For most people they peak in the first day or two after each injection and ease off by mid-week.

Mild fatigue and headache also appear on the common-side-effect list. Staying well hydrated helps with both. The MHRA Drug Safety Update of 29 January 2026 reinforces one symptom that should not be dismissed: severe, persistent stomach pain (especially if it radiates toward the back) requires prompt medical assessment, as it can indicate pancreatitis. This is uncommon but serious enough to act on quickly rather than wait and see.

Injection-site redness, itching or a small lump is normal and usually settles within a day. If it does not, or if you notice a widespread rash, tell your prescriber. You can also report any unexpected reactions through the MHRA Yellow Card scheme, it exists precisely so that real-world experience with newer medicines feeds back into safety monitoring.

Step 4, Appetite changes and what to do with them

By week two, many people notice their appetite is meaningfully smaller. Meals feel satisfying much sooner, snacking urges reduce, and some people find certain foods they previously craved hold less appeal. If you are considering whether a different formulation might suit you better, our Zepimax tirzepatide page explains how that option works and who it may be appropriate for.

The practical challenge at this stage is eating enough of the right things. A reduced appetite makes it tempting to eat very little, but protein adequacy, fibre intake and hydration matter more, not less, when you are losing weight. Aim to prioritise protein and vegetables at each smaller meal rather than simply eating less of whatever is convenient.

Weight changes at week two are usually modest. The clinical trials in the SURMOUNT programme ran for 72 weeks; meaningful and sustained results build over months, not a fortnight. If you are curious about how the starting dose tends to feel as it beds in, our guide to what to expect on 5 mg Mounjaro walks through the experience many people have as they settle into treatment. And if you are curious about the experience on the next dose level, our guide to what to expect on 10 mg Mounjaro describes how that stage typically feels for people further into their treatment journey. And if you are weighing up the full cost picture of private treatment, the Mounjaro cost page sets out how pricing works across the treatment journey.

Any questions about your progress, dose timing or how you are feeling belong with your prescriber. Our clinical team personally reviews every patient before any repeat or dose change, that is the kind of oversight that keeps treatment safe and effective. If you would like that clinical conversation, speak to our prescribers through a free consultation.